StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)

Close on Nov 17, 2026Market cap $4.87MP/E –Yield –

BioLineRx total assets

Total assets on the balance sheet at the end of each period.

BioLineRx's total assets was $33.48M at Jun 30, 2026. For fiscal 2025 it was $40.91M, up 5.1% from the year before. The highest annual figure on record is $81.39M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$40.91M+5.1%
FY2024Dec 31, 2024$38.91M-39.1%
FY2023Dec 31, 2023$63.93M-16.3%
FY2022Dec 31, 2022$76.38M-6.2%
FY2021Dec 31, 2021$81.39M+72.1%
FY2020Dec 31, 2020$47.29M-11.7%
FY2019Dec 31, 2019$53.57M-4.7%
FY2018Dec 31, 2018$56.23M-7.8%
FY2017Dec 31, 2017$60.97M+56.6%
FY2016Dec 31, 2016$38.94M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$33.48M-48.2%
Q4 FY2025Dec 31, 2025$40.91M-36.0%
Q2 FY2025Jun 30, 2025$43.27M-26.6%
Q4 FY2024Dec 31, 2024$38.91M-49.1%
Q2 FY2024Jun 30, 2024$64.60M-4.8%
Q4 FY2023Dec 31, 2023$63.93M-21.5%
Q2 FY2023Jun 30, 2023$58.94M-35.5%
Q4 FY2022Dec 31, 2022$76.38M+61.5%
Q2 FY2022Jun 30, 2022$67.84M+28.0%
Q4 FY2021Dec 31, 2021$81.39M+51.9%
Q2 FY2021Jun 30, 2021$91.33M+47.4%
Q4 FY2020Dec 31, 2020$47.29M-15.9%
Q2 FY2020Jun 30, 2020$52.99M+1.5%
Q4 FY2019Dec 31, 2019$53.57M-12.1%
Q2 FY2019Jun 30, 2019$61.96M+59.1%
Q4 FY2018Dec 31, 2018$56.23M–
Q2 FY2018Jun 30, 2018$52.21M–
Q4 FY2017Dec 31, 2017$60.97M–
Q4 FY2016Dec 31, 2016$38.94M–

More BioLineRx figures

See a number that looks wrong?